Evaluating the Utility of Polygenic Risk Scores in Identifying High-Risk Individuals for Eight Common Cancers is a research paper published in JNCI Cancer Spectrum (2020). On theSindex it has a DataRank of 0.749. It has been cited 146 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.749
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: R01CA202981
National Institutes of Health
Grant: R01CA235553
NCI NIH HHS
Grant: UM1 CA173640
Medical Research Council
Grant: MC_QA137853
NIDDK NIH HHS
Grant: P30 DK058404
Medical Research Council
Grant: MC_PC_17228
European Commission
Grant: 755394
International Randomized Study Comparing personalized, Risk-Stratified to Standard Breast Cancer Screening In Women Aged 40-70
National Institutes of Health
Grant: 5R01CA235553-02
Integrating genomic and transcriptomic data to identify breast cancer susceptibility genes
National Institutes of Health
Grant: 5R01CA202981-04
Breast Cancer genetic study in African-ancestry populations
Anne Potter Wilson chair endowment at Vanderbilt University
FWCI
15.70
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals
Additional file 2 of Polygenic risk score across distinct colorectal cancer screening outcomes: from premalignant polyps to colorectal cancer
Additional file 2 of Polygenic risk score across distinct colorectal cancer screening outcomes: from premalignant polyps to colorectal cancer
Additional file 1 of Gene–gene interaction of AhRwith and within the Wntcascade affects susceptibility to lung cancer
Additional file 1 of Gene–gene interaction of AhRwith and within the Wntcascade affects susceptibility to lung cancer
Additional file 2 of Clinically relevant combined effect of polygenic background, rare pathogenic germline variants, and family history on colorectal cancer incidence
Additional file 2 of Clinically relevant combined effect of polygenic background, rare pathogenic germline variants, and family history on colorectal cancer incidence
Additional file 1 of Genetic factors, adherence to healthy lifestyle behaviors, and risk of bladder cancer
Additional file 1 of Genetic factors, adherence to healthy lifestyle behaviors, and risk of bladder cancer
Additional file 1 of Impact of individual level uncertainty of lung cancer polygenic risk score (PRS) on risk stratification
Additional file 1 of Impact of individual level uncertainty of lung cancer polygenic risk score (PRS) on risk stratification
Additional file 2 of Impact of individual level uncertainty of lung cancer polygenic risk score (PRS) on risk stratification
Additional file 2 of Impact of individual level uncertainty of lung cancer polygenic risk score (PRS) on risk stratification
Additional file 3 of Polygenic risk score across distinct colorectal cancer screening outcomes: from premalignant polyps to colorectal cancer
Additional file 3 of Polygenic risk score across distinct colorectal cancer screening outcomes: from premalignant polyps to colorectal cancer
Additional file 1 of Polygenic risk score across distinct colorectal cancer screening outcomes: from premalignant polyps to colorectal cancer
Additional file 1 of Polygenic risk score across distinct colorectal cancer screening outcomes: from premalignant polyps to colorectal cancer
Additional file 4 of Polygenic risk score across distinct colorectal cancer screening outcomes: from premalignant polyps to colorectal cancer
Additional file 4 of Polygenic risk score across distinct colorectal cancer screening outcomes: from premalignant polyps to colorectal cancer